BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG, Jones CE, Kampmann B, Kotton CN, Lange C. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012;40:990-1013. [PMID: 22496318 DOI: 10.1183/09031936.00000712] [Cited by in Crossref: 168] [Cited by in F6Publishing: 175] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Kumwichar P, Chongsuvivatwong V. COVID-19 pneumonia and the subsequent risk of getting active pulmonary tuberculosis: a population-based dynamic cohort study using national insurance claims databases. EClinicalMedicine 2023;56:101825. [PMID: 36694864 DOI: 10.1016/j.eclinm.2023.101825] [Reference Citation Analysis]
2 Feredj E, Audureau E, Boueilh A, Fihman V, Fourati S, Lelièvre JD, Gallien S, Grimbert P, Matignon M, Melica G. Impact of a Dedicated Pretransplant Infectious Disease Consultation on Respiratory Tract Infections in Kidney Allograft Recipients: A Retrospective Study of 516 Recipients. Pathogens 2023;12. [PMID: 36678422 DOI: 10.3390/pathogens12010074] [Reference Citation Analysis]
3 Radisic MV, Pujato NR, Bravo PM, Del Grosso RC, Hunter M, Beltramino S, Linares González L, Cornet ML, Del Carmen Rial M, Franzini RL, Dotta AC, León LR, Walther J, Uva PD, Werber G. Tuberculosis treatment without rifampin in kidney/kidney-pancreas transplantation: A case series report. Transpl Infect Dis 2022;24:e13949. [PMID: 36515463 DOI: 10.1111/tid.13949] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Czech MM, Dioverti MV, Karaba AH, Jain T, Talluru SM, Sunshine JC, Kang J, Parrish N, Kates OS. Disseminated Tuberculosis With an Atypical Cutaneous Manifestation in a Hematopoietic Cell Transplant Patient in the Early Posttransplant Period: Case Report and Review of the Literature. Open Forum Infect Dis 2022;9:ofac643. [PMID: 36570971 DOI: 10.1093/ofid/ofac643] [Reference Citation Analysis]
5 Schaberg T, Brinkmann F, Feiterna-sperling C, Geerdes-fenge H, Hartmann P, Häcker B, Hauer B, Haas W, Heyckendorf J, Lange C, Maurer FP, Nienhaus A, Otto-knapp R, Priwitzer M, Richter E, Salzer HJ, Schoch O, Schönfeld N, Stahlmann R, Bauer T. Tuberkulose im Erwachsenenalter. Pneumologie 2022;76:727-819. [DOI: 10.1055/a-1934-8303] [Reference Citation Analysis]
6 Santin M, Perez-Recio S, Grijota MD, Anibarro L, Barcala JM, De Souza-Galvao ML, Gijon P, Luque R, Sanchez F; RIFAKiD team trial. Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial). PLoS One 2022;17:e0276387. [PMID: 36269714 DOI: 10.1371/journal.pone.0276387] [Reference Citation Analysis]
7 Sorohan BM, Ismail G, Tacu D, Obrișcă B, Ciolan G, Gîngu C, Sinescu I, Baston C. Mycobacterium Tuberculosis Infection after Kidney Transplantation: A Comprehensive Review. Pathogens 2022;11:1041. [DOI: 10.3390/pathogens11091041] [Reference Citation Analysis]
8 Compagno M, Navarra A, Campogiani L, Coppola L, Rossi B, Iannetta M, Malagnino V, Parisi SG, Mariotti B, Cerretti R, Arcese W, Goletti D, Andreoni M, Sarmati L. Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome. Int J Environ Res Public Health 2022;19. [PMID: 36078409 DOI: 10.3390/ijerph191710693] [Reference Citation Analysis]
9 Bednarova K, Slatinska J, Fabian O, Wohl P, Kopecka E, Viklicky O. Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-022-02916-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Maanaoui M, Hazzan M, Glowacki F, Hénon F, Bouyé S. Contre-indications temporaires à la transplantation rénale : sécuriser l’accès à la greffe. La Presse Médicale Formation 2022. [DOI: 10.1016/j.lpmfor.2022.07.006] [Reference Citation Analysis]
11 Behr MA, Lapierre SG, Kunimoto DY, Lee RS, Long R, Sekirov I, Soualhine H, Turenne CY. Chapter 3: Diagnosis of tuberculosis disease and drug-resistant tuberculosis. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022;6:33-48. [DOI: 10.1080/24745332.2022.2035638] [Reference Citation Analysis]
12 Long R, Divangahi M, Schwartzman K. Chapter 2: Transmission and pathogenesis of tuberculosis. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022;6:22-32. [DOI: 10.1080/24745332.2022.2035540] [Reference Citation Analysis]
13 Kattner AA. The best protection is early detection. Biomed J 2022:S2319-4170(22)00020-8. [PMID: 35042015 DOI: 10.1016/j.bj.2022.01.010] [Reference Citation Analysis]
14 McCort M, MacKenzie E, Pursell K, Pitrak D. Bacterial infections in lung transplantation. J Thorac Dis 2021;13:6654-72. [PMID: 34992843 DOI: 10.21037/jtd-2021-12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
15 Zou J, Wang T, Qiu T, Chen Z, Zhou J, Ma X, Jin Z, Xu Y, Zhang L. Clinical characteristics of tuberculous infection following renal transplantation. Transpl Immunol 2022;70:101523. [PMID: 34973371 DOI: 10.1016/j.trim.2021.101523] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Bartoletti M, Rinaldi M, Bussini L, Giannella M, Viale P. Infections in the Liver Transplant Recipient. Textbook of Liver Transplantation 2022. [DOI: 10.1007/978-3-030-82930-8_19] [Reference Citation Analysis]
17 Varughese S, Sahay M, Shah D, Nagvekar V, Jha V. Evaluation and management of tuberculosis in solid organ transplant recipients: South Asian expert group opinion. Indian J Transplant 2022;16:15. [DOI: 10.4103/ijot.ijot_18_22] [Reference Citation Analysis]
18 Rashid HU, Begum NAS, Kashem TS. Mycobacterial infections in solid organ transplant recipients. Korean J Transplant 2021;35:208-17. [DOI: 10.4285/kjt.21.0033] [Reference Citation Analysis]
19 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Sunder T. The evolution of lung transplantation in India and the current scenario. Indian J Thorac Cardiovasc Surg 2021;:1-18. [PMID: 34744333 DOI: 10.1007/s12055-021-01248-4] [Reference Citation Analysis]
21 Kwon DE, Han SH, Han KD, La Y, Lee KH. Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high-endemic country. Transpl Infect Dis 2021;23:e13729. [PMID: 34505751 DOI: 10.1111/tid.13729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Slomovich S, Oh KT, Diakos NA, Restaino SW, Clerkin KJ, Latif F, Miyauchi JT, Lee A, Sayer GT, Uriel N. A Rare Case of Disseminated Tuberculosis and Hematological Malignancy in a Heart Transplant Recipient. Transplant Proc 2021:S0041-1345(21)00508-X. [PMID: 34399971 DOI: 10.1016/j.transproceed.2021.07.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Dodani SK, Nasim A, Aziz T, Naqvi A. The efficacy of isoniazid prophylaxis in renal transplant recipients in a high tuberculosis burden country. Transpl Infect Dis 2021;:e13709. [PMID: 34331355 DOI: 10.1111/tid.13709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Nasir N, Sarfaraz S, Khanum I, Ansari T, Nasim A, Dodani SK, Luxmi S. Tuberculosis in Solid Organ Transplantation: Insights from TB Endemic Areas. Curr Infect Dis Rep 2021;23. [DOI: 10.1007/s11908-021-00756-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Seetharam SJ, Rajaraman V, Halanaik D. Tuberculosis in Posttransplant Recipients: Challenges in Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Reporting in Countries with a High Prevalence of Tuberculosis. Indian J Nucl Med 2021;36:189-92. [PMID: 34385792 DOI: 10.4103/ijnm.ijnm_225_20] [Reference Citation Analysis]
26 Bergeron A. Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions! Bone Marrow Transplant 2021;56:2050-1. [PMID: 34145415 DOI: 10.1038/s41409-021-01381-z] [Reference Citation Analysis]
27 Malinis M, Koff A. Mycobacterium tuberculosis in solid organ transplant donors and recipients. Curr Opin Organ Transplant 2021;26:432-9. [PMID: 34074939 DOI: 10.1097/MOT.0000000000000885] [Reference Citation Analysis]
28 Shiari A, Nassar M, Soubani AO. Major pulmonary complications following Hematopoietic stem cell transplantation: What the pulmonologist needs to know. Respir Med 2021;185:106493. [PMID: 34107323 DOI: 10.1016/j.rmed.2021.106493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Meinerz G, Silva CKD, Dorsdt DMB, Adames JB, Andrade JP, Ventura PE, Monteiro AA, Pasqualotto AC, Garcia VD, Keitel E. Latent tuberculosis screening before kidney transplantation in the South of Brazil. J Bras Nefrol 2021;43:520-9. [PMID: 33999988 DOI: 10.1590/2175-8239-JBN-2020-0189] [Reference Citation Analysis]
30 de Oliveira Rodrigues M, de Almeida Testa LH, Dos Santos ACF, Zanetti LP, da Silva Ruiz L, de Souza MP, Colturato VR, Machado CM. Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study. Bone Marrow Transplant 2021;56:2241-7. [PMID: 33966056 DOI: 10.1038/s41409-021-01329-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Clemente WT, Faria LC, Cota GF, Amado LRN, Oliveira JGF, de Miranda SS, Cançado OL Jr, Romanelli RMC, Lima AS, Frade LB, Lucas F Jr, Sanches MD. Donor-Derived Tuberculosis: A Case Report and the Role of Communication Gaps in Transplantation Safety. Case Rep Transplant 2021;2021:8816426. [PMID: 33959403 DOI: 10.1155/2021/8816426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kapoor J, Mirgh SP, Khushoo V, Mehta P, Ahmed R, Bansal N, Bhurani D, Agrawal N. Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it out. Ther Adv Infect Dis 2021;8:20499361211008674. [PMID: 33912346 DOI: 10.1177/20499361211008674] [Reference Citation Analysis]
33 Runyo F, Matignon M, Audureau E, Vindrios W, Boueilh A, Gomart C, Grimbert P, Gallien S, Melica G. Infectious disease consultation is effective in boosting vaccine coverage in patients awaiting kidney transplantation: A French prospective study. Transpl Infect Dis 2021;:e13607. [PMID: 33773002 DOI: 10.1111/tid.13607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Grijota-Camino MD, Montero N, Luque MJ, Díaz-Jurado M, Sabé N, Pérez-Recio S, Couceiro C, Muñoz L, Cruzado JM, Santin M. Tuberculosis prevention in patients undergoing kidney transplantation: A nurse-led program for screening and treatment. Transpl Infect Dis 2021;:e13603. [PMID: 33745229 DOI: 10.1111/tid.13603] [Reference Citation Analysis]
35 Dodani S, Nasim A, Aziz T, Naqvi A. The Efficacy of Isoniazid Prophylaxis in Renal Transplant Recipients in a High TB Burden Country.. [DOI: 10.1101/2021.02.28.21252563] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Dubois M, Dixit A, Lamb G. Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients. Glob Pediatr Health 2021;8:2333794X20981548. [PMID: 33506075 DOI: 10.1177/2333794X20981548] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Pellett Madan R, Danziger-isakov LA. Infectious disease evaluation of infants and children awaiting solid organ or hematopoietic stem cell transplant. Pediatric Transplant and Oncology Infectious Diseases 2021. [DOI: 10.1016/b978-0-323-64198-2.00013-0] [Reference Citation Analysis]
38 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2021. [DOI: 10.1007/978-3-030-25869-6_15] [Reference Citation Analysis]
39 Milburn H. Tuberculosis in Renal Disease. Tuberculosis in Clinical Practice 2021. [DOI: 10.1007/978-3-030-75509-6_7] [Reference Citation Analysis]
40 Munoz FM, Ling Lin P. Nontuberculous and tuberculous Mycobacterium. Pediatric Transplant and Oncology Infectious Diseases 2021. [DOI: 10.1016/b978-0-323-64198-2.00025-7] [Reference Citation Analysis]
41 Martin L, Russell G. Anti-tumour Necrosis Alpha Factor Treatment, Immunosuppression and Chemotherapy Prophylaxis. Tuberculosis in Clinical Practice 2021. [DOI: 10.1007/978-3-030-75509-6_17] [Reference Citation Analysis]
42 Menon J, Miraje B, Patel K, Vij M, Hakeem A, Devarajan V, Shanmugam N, Srinivas Reddy M, Rela M. Primary tuberculosis of the graft masquerading pyogenic liver abscess in a pediatric liver recipient. Transpl Infect Dis 2021;23:e13533. [PMID: 33280197 DOI: 10.1111/tid.13533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Bamford A, Dixon G, Klein N, Marks SD, Ritz N, Welch SB, Tebruegge M. Preventing tuberculosis in paediatric kidney transplant recipients: is there a role for BCG immunisation pre-transplantation in low tuberculosis incidence countries? Pediatr Nephrol 2020. [PMID: 33245418 DOI: 10.1007/s00467-020-04844-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
44 Korayem GB, Alissa DA, AlSuhaibani NI, AlSwailem GS, AlShammari MA, Yaqoob I, Aljasser DS, Almaghrabi RS. Empiric vs screening-based use of isoniazid for tuberculosis prophylaxis: Safety and effectiveness in lung transplant recipients in Saudi Arabia. Transpl Infect Dis 2021;23:e13473. [PMID: 32978858 DOI: 10.1111/tid.13473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Shu CC, Tsai MK, Lin SW, Wang JY, Yu CJ, Lee CY. Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control. Clin Infect Dis 2020;71:914-23. [PMID: 32620949 DOI: 10.1093/cid/ciz851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
46 Solé A, Part-lopez M, Saez B, Laporta R, Anguera G, Cuesta VM, De Pablo A, Canyada-martinez AJ, Pastor A, Gil A, Caminero JA, Bravo C. Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin. Archivos de Bronconeumología 2020;56:493-8. [DOI: 10.1016/j.arbres.2019.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
47 Solé A, Part-lopez M, Saez B, Laporta R, Anguera G, Cuesta VM, De Pablo A, Canyada-martinez AJ, Pastor A, Gil A, Caminero JA, Bravo C. Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin. Archivos de Bronconeumología (English Edition) 2020;56:493-498. [DOI: 10.1016/j.arbr.2019.10.017] [Reference Citation Analysis]
48 Sosa-Moreno A, Narita M, Spitters C, Swetky M, Podczervinski S, Lind ML, Holmberg L, Liu C, Edelstein R, Pergam SA. A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients. Open Forum Infect Dis 2020;7:ofaa224. [PMID: 32671130 DOI: 10.1093/ofid/ofaa224] [Reference Citation Analysis]
49 Mahmoudi S, Pourakbari B, Sadeghi RH, Hamidieh AA, Safari Sharari A, Salajegheh P, Aziz-Ahari A, Mamishi S. High prevalence of latent tuberculosis in hematopoietic stem cell transplant recipients: A First Report. Pediatr Transplant 2020;24:e13770. [PMID: 32573900 DOI: 10.1111/petr.13770] [Reference Citation Analysis]
50 Barton E, Gao Y, Ball D, Fidler K, Klein N, Curtis N, Clifford V, Marshall BG, Chancellor A, Mansour S, Elkington P, Tebruegge M. Calcineurin Inhibitors and Variation in the Performance of Interferon-γ Release Assays Used to Detect Tuberculosis Infection. Ann Am Thorac Soc 2019;16:771-5. [PMID: 30811214 DOI: 10.1513/AnnalsATS.201811-784RL] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
51 Zeng Q, Zhang Y, Wu Y, Zhang Z, Zhang J, Fu H, Wang J, Wang F, Yan C, Mo X, Wang Y, Chen Y, Chang Y, Xu L, Liu K, Huang X, Zhang X. Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2020;26:1203-9. [DOI: 10.1016/j.bbmt.2020.02.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
52 Gitman M, Vu J, Nguyen T, Chen C, Rotstein C. Evaluation of a routine screening program with tuberculin skin testing on rates of detection of latent tuberculosis infection and prevention of active tuberculosis in patients with multiple myeloma at a Canadian cancer centre. Curr Oncol 2020;27:e246-50. [PMID: 32669929 DOI: 10.3747/co.27.5577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Primaturia C, Reniarti L, Nataprawira HMN. Comparison between the Interferon γ Release Assay-QuantiFERON Gold Plus (QFT-Plus)-and Tuberculin Skin Test (TST) in the Detection of Tuberculosis Infection in Immunocompromised Children. Pulm Med 2020;2020:7159485. [PMID: 32455014 DOI: 10.1155/2020/7159485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
54 Helleberg M, Cho D, Ekenberg C, Sørensen S, Rix M, Gustafsson F, Rasmussen A, Perch M, Andersen PHS, Lundgren JD, Andersen AB. Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017. Tuberc Res Treat 2020;2020:7636975. [PMID: 32395341 DOI: 10.1155/2020/7636975] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
55 Kamboj D, Gupta P, Basil MV, Mohan A, Guleria R, Bhatnagar A, Mehta G, Kumar P, Saurabh A, Deepak R, Thakral D, Misra P, Tandon R, Gupta UD, Mitra DK. Improved Mycobacterium tuberculosis clearance after the restoration of IFN‐γ + TNF‐α + CD4 + T cells: Impact of PD‐1 inhibition in active tuberculosis patients. Eur J Immunol 2020;50:736-47. [DOI: 10.1002/eji.201948283] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
56 Kumar R, Ison MG. Opportunistic Infections in Transplant Patients. Infect Dis Clin North Am 2019;33:1143-57. [PMID: 31668195 DOI: 10.1016/j.idc.2019.05.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
57 Bourlon C, Camacho-Hernández R, Fierro-Angulo OM, Acosta-Medina AA, Bourlon MT, Niembro-Ortega MD, Gonzalez-Lara MF, Sifuentes-Osornio J, Ponce-de-León A. Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population. Biol Blood Marrow Transplant 2020;26:1350-4. [PMID: 32200119 DOI: 10.1016/j.bbmt.2020.03.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
58 Sayyahfar S, Mahdavi M, Seyedi Arani S, Fotovati Z. Comparison of tuberculin skin test and interferon gamma release assay in pediatric candidates of heart transplantation and a 2-year follow-up. Transpl Infect Dis 2020;22:e13268. [PMID: 32072713 DOI: 10.1111/tid.13268] [Reference Citation Analysis]
59 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2020. [DOI: 10.1007/978-3-030-01751-4_15-1] [Reference Citation Analysis]
60 Yang A, Shi J, Luo Y, Ye Y, Tan Y, Huang H, Zhao Y. Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis. Sci Rep 2019;9:20402. [PMID: 31892702 DOI: 10.1038/s41598-019-56013-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
61 Abad CL, Razonable RR. Prevention and treatment of tuberculosis in solid organ transplant recipients. Expert Rev Anti Infect Ther 2020;18:63-73. [PMID: 31826668 DOI: 10.1080/14787210.2020.1704255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
62 Pettipher C, Benitha R. Tuberculosis in biologic users for rheumatic diseases: results from the South African Biologics Registry (SABIO). Ann Rheum Dis 2020;79:292-9. [DOI: 10.1136/annrheumdis-2019-216128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
63 Alrajhi AA, Alotaibi J, Alghamdi AM, Almanea H, Alsebayel M, Al‐meshari K, Al‐hajoj S. Mycobacterium tuberculosis DNA in living donor transplanted livers and donor‐related tuberculosis in recipients: A retrospective longitudinal cohort study. Transpl Infect Dis 2019;22. [DOI: 10.1111/tid.13212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
64 Leong LY, Lin PC, Chi CY, Chou CH, Lu MC, Liao WC, Ho MW, Wang JH, Jeng LB. Risk factors of tuberculosis after liver transplant in a tertiary care hospital. J Microbiol Immunol Infect 2021;54:312-8. [PMID: 31668794 DOI: 10.1016/j.jmii.2019.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
65 Abad CLR, Deziel PJ, Razonable RR. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review. Transpl Infect Dis 2019;21:e13178. [PMID: 31541575 DOI: 10.1111/tid.13178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
66 Rafiei N, Williams J, Mulley WR, Trauer JM, Jenkin GA, Rogers BA. Mycobacterium tuberculosis: Active disease and latent infection in a renal transplant cohort. Nephrology (Carlton) 2019;24:569-74. [PMID: 29660203 DOI: 10.1111/nep.13386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
67 Uzorka JW, Wallinga J, Kroft LJM, Ottenhoff THM, Arend SM. Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis. Open Forum Infect Dis 2019;6:ofz313. [PMID: 31363778 DOI: 10.1093/ofid/ofz313] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
68 Maung Myint T, Rogerson TE, Noble K, Craig JC, Webster AC. Tests for latent tuberculosis in candidates for solid organ transplantation: A systematic review and meta-analysis. Clin Transplant 2019;33:e13643. [PMID: 31225918 DOI: 10.1111/ctr.13643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
69 Eswarappa M, H J GD, John MM, Chennabasappa GK, Siddaiah GM. Tuberculosis in renal transplant recipients: Our decade long experience with an opportunistic invader. Indian J Tuberc 2020;67:73-8. [PMID: 32192621 DOI: 10.1016/j.ijtb.2019.05.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
70 . Mycobacterium tuberculosis : Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2018;61:100-15. [PMID: 29356839 DOI: 10.1007/s00103-017-2660-4] [Reference Citation Analysis]
71 Viana LA, Cristelli MP, Santos DW, Tavares MG, Dantas MTC, Felipe CR, Silva HT, Pestana JM. Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: A retrospective cohort analysis. Am J Transplant 2019;19:1421-31. [PMID: 30556285 DOI: 10.1111/ajt.15220] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
72 Fishman JA. Mycobacterium tuberculosis in transplantation: Immunity sufficient to perpetuate disease? Am J Transplant 2019;19:1262-3. [PMID: 30614189 DOI: 10.1111/ajt.15254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
73 Wolfe CR, Ison MG; AST Infectious Diseases Community of Practice. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:e13547. [PMID: 30903670 DOI: 10.1111/ctr.13547] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
74 Subramanian AK, Theodoropoulos NM; Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant 2019;33:e13513. [PMID: 30817030 DOI: 10.1111/ctr.13513] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 12.3] [Reference Citation Analysis]
75 Krishnamoorthy S, Kumaresan N, Zumla A. Latent tuberculosis infection and renal transplantation – Diagnosis and management. International Journal of Infectious Diseases 2019;80:S73-6. [DOI: 10.1016/j.ijid.2019.01.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
76 Nasiri MJ, Pormohammad A, Goudarzi H, Mardani M, Zamani S, Migliori GB, Sotgiu G. Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA. Infection 2019;47:353-61. [PMID: 30805899 DOI: 10.1007/s15010-019-01285-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
77 Ertuğrul G, Düger M. Prophylaxis for latent tuberculosis infection in liver transplant recipients. Journal of Surgery and Medicine 2019. [DOI: 10.28982/josam.527957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Burel JG, Babor M, Pomaznoy M, Lindestam Arlehamn CS, Khan N, Sette A, Peters B. Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis. Front Immunol 2019;10:221. [PMID: 30837989 DOI: 10.3389/fimmu.2019.00221] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
79 Brockhaus L, Brune J, Battegay R, Gerull S, Nägele M, Bättig V. [Disseminated tuberculosis during induction chemotherapy in acute myeloid leukemia]. Internist (Berl) 2019;60:634-7. [PMID: 30762085 DOI: 10.1007/s00108-019-0565-z] [Reference Citation Analysis]
80 van Leth F, Brinkmann F, Cirillo DM, Dheda K, Duarte R, Guglielmetti L, Kuksa L, Lange C, Mitnick C, Skrahina A, Zaman K, Bothamley G. The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation. Eur Respir J 2019;53:1802089. [PMID: 30606765 DOI: 10.1183/13993003.02089-2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
81 Muller E. Kidney Transplantation in Developing Countries. Kidney Transplantation - Principles and Practice 2019. [DOI: 10.1016/b978-0-323-53186-3.00038-3] [Reference Citation Analysis]
82 Portal-celhay C, Philips JA. Tuberculosis. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Fishman JA, Costa SF, Alexander BD. Infection in Kidney Transplant Recipients. Kidney Transplantation - Principles and Practice 2019. [DOI: 10.1016/b978-0-323-53186-3.00031-0] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
84 Morales MK, Cooper M, Abrams P, Timpone JG. Infections in Kidney and Pancreas Transplantation. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_4] [Reference Citation Analysis]
85 Cahuayme-Zuniga LJ, Brust KB. Mycobacterial Infections in Patients With Chronic Kidney Disease and Kidney Transplantation. Adv Chronic Kidney Dis 2019;26:35-40. [PMID: 30876615 DOI: 10.1053/j.ackd.2018.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
86 Philley JV, Griffith DE. Antimycobacterial Consideration in Transplantation Including Drug Non-susceptibility and Resistance: Tuberculosis and Nontuberculous Mycobacterial Disease. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_56] [Reference Citation Analysis]
87 Kowada A. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective. Journal of Infection 2019;78:58-65. [DOI: 10.1016/j.jinf.2018.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
88 Sester M. Tuberculosis in immunocompromised patients. ERS Handbook Respiratory Medicine 2019. [DOI: 10.1183/9781849840798.008518] [Reference Citation Analysis]
89 Meije Y, Kwak EJ, Aguado JM. Prevention and Treatment of Mycobacterial Infections. Infectious Diseases in Solid-Organ Transplant Recipients 2019. [DOI: 10.1007/978-3-030-15394-6_14] [Reference Citation Analysis]
90 Marriott DJ, Orla Morrissey C. Common Infections Following Lung Transplantation. Essentials in Lung Transplantation 2019. [DOI: 10.1007/978-3-319-90933-2_15] [Reference Citation Analysis]
91 Muñoz P, Stosor T. Management of CNS Infections. Infectious Diseases in Solid-Organ Transplant Recipients 2019. [DOI: 10.1007/978-3-030-15394-6_17] [Reference Citation Analysis]
92 Bosch A, Valour F, Dumitrescu O, Dumortier J, Radenne S, Pages-Ecochard M, Chidiac C, Ferry T, Perpoint T, Miailhes P, Conrad A, Goutelle S, Ader F; Lyon TB study Group. A practical approach to tuberculosis diagnosis and treatment in liver transplant recipients in a low-prevalence area. Med Mal Infect. 2019;49:231-240. [PMID: 30591271 DOI: 10.1016/j.medmal.2018.11.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
93 Magis-escurra C, Carvalho ACC, Kritski AL, Girardi E. Tuberculosis and comorbidities. Tuberculosis. [DOI: 10.1183/2312508x.10022017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
94 Santoro-Lopes G, Subramanian AK, Molina I, Aguado JM, Rabagliatti R, Len O. Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors. Transplantation. 2018;102:S60-S65. [PMID: 29381579 DOI: 10.1097/tp.0000000000002014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
95 Ryu MR, Park MS, Cho EH, Jung CW, Kim K, Kim SJ, Oh HY, Huh W, Jang HR, Koh WJ, Park HY, Kim YH, Sinn DH, Choi JO, Joh JW, Kim JM, Kim SJ, Park JB, Kang ES. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients. J Clin Microbiol 2018;56:e00438-18. [PMID: 30135226 DOI: 10.1128/JCM.00438-18] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
96 Salvador NGA, Wee SY, Lin CC, Wu CC, Lu HI, Lin TL, Lee WF, Chan YC, Lin LM, Chen CL. Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver Transplantation. Ann Transplant 2018;23:733-43. [PMID: 30337516 DOI: 10.12659/AOT.911034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
97 Qiu J, Liu S, Wang Q. Treatment of tuberculosis infection complicated with liver transplant. Infection International 2018;7:81-7. [DOI: 10.2478/ii-2018-0025] [Reference Citation Analysis]
98 Hasan T, Au E, Chen S, Tong A, Wong G. Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines. BMJ Open 2018;8:e022445. [PMID: 30209157 DOI: 10.1136/bmjopen-2018-022445] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
99 Samano MN, Fernandes LM, Campos SV, Pêgo-fernandes PM. Lung Transplantation in Tuberculosis. The Annals of Thoracic Surgery 2018;106:934. [DOI: 10.1016/j.athoracsur.2018.03.065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
100 Riccardi N, Cenderello G, Borroni E, Rutigliani M, Cirillo DM. A case report of mucocutaneous tuberculosis after orthotopic liver transplantation: a challenging diagnosis. BMC Infect Dis 2018;18:431. [PMID: 30157783 DOI: 10.1186/s12879-018-3347-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
101 Uzorka JW, Delfos NM, Witte AMC, Scheper H, van Soolingen D, Arend SM. Tuberculosis after a borderline QuantiFERON result during screening before infliximab. Eur Respir J 2018;52:1800913. [PMID: 30072541 DOI: 10.1183/13993003.00913-2018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
102 Gras J, De Castro N, Montlahuc C, Champion L, Scemla A, Matignon M, Lachâtre M, Raskine L, Grall N, Peraldi MN, Molina JM. Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area. Transpl Infect Dis 2018;20:e12943. [DOI: 10.1111/tid.12943] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
103 Uzorka JW, Bossink AWJ, Franken WPJ, Thijsen SFT, Leyten EMS, van Haeften AC, Doornenbal G, Boonstra P, Ottenhoff THM, Arend SM. Borderline QuantiFERON results and the distinction between specific responses and test variability. Tuberculosis (Edinb) 2018;111:102-8. [PMID: 30029893 DOI: 10.1016/j.tube.2018.06.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
104 Akı ŞZ, Sucak GT, Tunçcan ÖG, Köktürk N, Şenol E. The incidence of tuberculosis infection in hematopoietic stem cell transplantation recipients: A retrospective cohort study from a center in Turkey. Transpl Infect Dis 2018;20:e12912. [DOI: 10.1111/tid.12912] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
105 Wu W, Yang M, Xu M, Ding C, Li Y, Xu K, Shen J, Li L. Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China. PLoS One 2018;13:e0195695. [PMID: 29659613 DOI: 10.1371/journal.pone.0195695] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
106 Cho SY, Lee HJ, Lee DG. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. Korean J Intern Med 2018;33:256-76. [PMID: 29506345 DOI: 10.3904/kjim.2018.036] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
107 Sayyahfar S, Davoodzadeh F, Hoseini R, Rahimzadeh N, Otukesh H. Comparison of tuberculin skin test and interferon gamma release assay for diagnosis of latent tuberculosis infection in pediatric candidates of renal transplantation. Pediatr Transplant 2018;22. [PMID: 29388291 DOI: 10.1111/petr.13148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
108 Agrawal N, Aggarwal M, Kapoor J, Ahmed R, Shrestha A, Kaushik M, Bhurani D. Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation. Transpl Infect Dis 2018;20:e12794. [DOI: 10.1111/tid.12794] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
109 Pena T, Klesney-Tait J. Mycobacterial Infections in Solid Organ and Hematopoietic Stem Cell Transplantation. Clin Chest Med 2017;38:761-70. [PMID: 29128024 DOI: 10.1016/j.ccm.2017.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
110 Al-mukhaini SM, Al-eid H, Alduraibi F, Hakami HI, Al Talhi H, Shoukri M, Ahmed AM, Ahmed Y, Alrajhi AA. Mycobacterium Tuberculosis in Solid Organ Transplantation: Incidence before and after Expanded Isoniazid Prophylaxis. Ann Saudi Med 2017;37:138-43. [DOI: 10.5144/0256-4947.2017.138] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
111 Anand M, Nayyar E, Concepcion B, Salani M, Schaefer H. Tuberculosis in kidney transplant recipients: A case series. World J Transplant 2017; 7(3): 213-221 [PMID: 28698838 DOI: 10.5500/wjt.v7.i3.213] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
112 Cantini F, Nannini C, Niccoli L, Petrone L, Ippolito G, Goletti D. Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics. Mediators Inflamm 2017;2017:8909834. [PMID: 28659665 DOI: 10.1155/2017/8909834] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 11.5] [Reference Citation Analysis]
113 Huaman MA, Brawley R, Ashkin D. Multidrug-resistant tuberculosis in transplant recipients: Case report and review of the literature. Transpl Infect Dis 2017;19:e12672. [DOI: 10.1111/tid.12672] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
114 Jambaldorj E, Han M, Jeong JC, Koo TY, Min SI, Song EY, Ha J, Ahn C, Yang J. Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country. BMC Nephrol 2017;18:88. [PMID: 28292277 DOI: 10.1186/s12882-017-0506-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
115 Bartoletti M, Martelli G, Tedeschi S, Morelli M, Bertuzzo V, Tadolini M, Pianta P, Cristini F, Giannella M, Lewis RE, Pinna AD, Viale P. Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment. Transpl Infect Dis 2017;19:e12658. [DOI: 10.1111/tid.12658] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
116 Lee HJ, Lee DG, Choi SM, Park SH, Cho SY, Choi JK, Kim SH, Choi JH, Yoo JH, Cho BS, Eom KS, Lee S, Kim YJ, Kim HJ, Min CK, Kim DW, Lee JW, Min WS, Jung JI. The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population. PLoS One 2017;12:e0173250. [PMID: 28278166 DOI: 10.1371/journal.pone.0173250] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
117 Mcculloch M, Lin PL. Globalization of pediatric transplantation: The risk of tuberculosis or not tuberculosis. Pediatr Transplantation 2017;21:e12891. [DOI: 10.1111/petr.12891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
118 Muñoz P, Giannella M, Bouza E. Heart, Lung and Heart–Lung Transplantation. Infectious Diseases 2017. [DOI: 10.1016/b978-0-7020-6285-8.00081-2] [Reference Citation Analysis]
119 Baghban A, Azar MM, Bernardo RM, Malinis M. Disseminated Mycobacterium tuberculosis following renal transplant with alemtuzumab induction. BMJ Case Rep 2016;2016:bcr2016217998. [PMID: 27852682 DOI: 10.1136/bcr-2016-217998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
120 Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, Ottenhoff TH, Denkinger CM, Goletti D. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J 2016;48:1751-63. [PMID: 27836953 DOI: 10.1183/13993003.01012-2016] [Cited by in Crossref: 126] [Cited by in F6Publishing: 133] [Article Influence: 18.0] [Reference Citation Analysis]
121 Muñoz L, Santin M. Prevention and Management of Tuberculosis in Transplant Recipients: From Guidelines to Clinical Practice. Transplantation 2016;100:1840-52. [DOI: 10.1097/tp.0000000000001224] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
122 Simner PJ, Woods GL, Wengenack NL, Hayden RT, Wolk DM, Carroll KC, Tang Y. Mycobacteria. Microbiol Spectr 2016;4. [DOI: 10.1128/microbiolspec.dmih2-0016-2015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Marmor R, Logan C, Hemming A, Berumen J. Fever, Cough, and Right Lower Quadrant Abdominal Pain in a Liver Transplant Recipient. Am J Transplant 2016;16:1933-5. [DOI: 10.1111/ajt.13772] [Reference Citation Analysis]
124 Simner PJ, Woods GL, Wengenack NL. Mycobacteria. Diagnostic Microbiology of the Immunocompromised Host 2016. [DOI: 10.1128/9781555819040.ch16] [Reference Citation Analysis]
125 Hermansen TS, Lillebaek T, Langholz Kristensen K, Andersen PH, Ravn P. Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country. Thorax 2016;71:652-8. [PMID: 27030576 DOI: 10.1136/thoraxjnl-2015-208228] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
126 Multiple Choice Questions with explanations. ERS Handbook Self-Assessment in Respiratory Medicine. [DOI: 10.1183/9781849840781-ch1] [Reference Citation Analysis]
127 Question 242. ERS Handbook Self-Assessment in Respiratory Medicine. [DOI: 10.1183/9781849840781.242] [Reference Citation Analysis]
128 Sauzullo I, Vullo V, Mastroianni CM. Detecting latent tuberculosis in compromised patients. Curr Opin Infect Dis 2015;28:275-82. [PMID: 25887610 DOI: 10.1097/QCO.0000000000000158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
129 van Rijn SP, van Altena R, Akkerman OW, van Soolingen D, van der Laan T, de Lange WC, Kosterink JG, van der Werf TS, Alffenaar JC. Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis. Eur Respir J 2016;47:1229-34. [DOI: 10.1183/13993003.01654-2015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
130 Lange C, Mandalakas AM, Kalsdorf B, Denkinger CM, Sester M. Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence. Pathog Immun 2016;1:308-29. [PMID: 28217762 DOI: 10.20411/pai.v1i2.173] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
131 Kotton CN. Travel Medicine, Vaccines, and Transplant Tourism. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_50] [Reference Citation Analysis]
132 Lee I, Blumberg EA. Risk and Epidemiology of Infections After Solid Organ Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
133 Theodoropoulos N, Ison MG. Donor-Derived Infections: Incidence, Prevention, and Management. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_8] [Reference Citation Analysis]
134 Ali HA, Palmer SM, Manuel O. Special Considerations for Long-Term Survivors After Solid Organ Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_53] [Reference Citation Analysis]
135 Machado CM. Transplant Infections in Developing Countries. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
136 Bucher JN, Schoenberg MB, Freytag I, Lange U, Hofmann-thiel S, Guba MO, Werner J, Eder A, Schelling G, Stangl M. Donor-derived tuberculosis after solid organ transplantation in two patients and a staff member. Infection 2016;44:365-70. [DOI: 10.1007/s15010-015-0853-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
137 Meije Y, Piersimoni C, Torre-Cisneros J, Dilektasli AG, Aguado JM; ESCMID Study Group of Infection in Compromised Hosts. Mycobacterial infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20 Suppl 7:89-101. [PMID: 24707957 DOI: 10.1111/1469-0691.12641] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
138 Scholman T, Straub M, Sotgiu G, Elsäßer J, Leyking S, Singh M, Sester U, Wagner D, Sester M. Superior Sensitivity of Ex Vivo IFN-γ Release Assays as Compared to Skin Testing in Immunocompromised Patients. Am J Transplant 2015;15:2616-24. [PMID: 26014909 DOI: 10.1111/ajt.13330] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
139 Pierrotti LC, Kotton CN. Transplantation in the tropics: lessons on prevention and management of tropical infectious diseases. Curr Infect Dis Rep 2015;17:492. [PMID: 26031964 DOI: 10.1007/s11908-015-0492-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
140 Purvey S, Lu K, Mukkamalla SK, Anandi P, Dumitriu B, Kranick S, Hammoud DA, O'Connell E, Oh AL, Barrett J, Mahanty S, Battiwalla M. Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review. Transpl Infect Dis 2015;17:456-62. [PMID: 25850995 DOI: 10.1111/tid.12392] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
141 Benito N, García-Vázquez E, Horcajada JP, González J, Oppenheimer F, Cofán F, Ricart MJ, Rimola A, Navasa M, Rovira M, Roig E, Pérez-Villa F, Cervera C, Moreno A. Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study. Clin Microbiol Infect 2015;21:651-8. [PMID: 25882369 DOI: 10.1016/j.cmi.2015.03.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
142 Muñoz L, Gomila A, Casas S, Castellote J, Arnan M, Rafecas A, Santin M. Immunodiagnostic Tests' Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study. Transplant Direct 2015;1:e12. [PMID: 27500217 DOI: 10.1097/TXD.0000000000000520] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
143 Pan L, Jia H, Liu F, Sun H, Gao M, Du F, Xing A, Du B, Sun Q, Wei R, Gu S, Zhang Z. Risk factors for false-negative T-SPOT.TB assay results in patients with pulmonary and extra-pulmonary TB. Journal of Infection 2015;70:367-80. [DOI: 10.1016/j.jinf.2014.12.018] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
144 Diel R, Lampenius N, Nienhaus A. Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations. PharmacoEconomics 2015;33:783-809. [DOI: 10.1007/s40273-015-0267-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
145 Sidhu A, Verma G, Humar A, Kumar D. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Transplantation. 2014;98:671-675. [PMID: 24825525 DOI: 10.1097/tp.0000000000000133] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
146 Eom KS, Lee DG, Lee HJ, Cho SY, Choi SM, Choi JK, Kim YJ, Lee S, Kim HJ, Cho SG, Lee JW. Tuberculosis before hematopoietic stem cell transplantation in patients with hematologic diseases: report of a single-center experience. Transpl Infect Dis 2015;17:73-9. [PMID: 25620389 DOI: 10.1111/tid.12341] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
147 Giannella M, Bartoletti M, Viale P. Infection Complications After Abdominal Organ Transplantation. Abdominal Solid Organ Transplantation 2015. [DOI: 10.1007/978-3-319-16997-2_2] [Reference Citation Analysis]
148 Sun H. Treating tuberculosis in solid organ transplant recipients. Current Opinion in Infectious Diseases 2014;27:501-5. [DOI: 10.1097/qco.0000000000000102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
149 Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens J, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C. Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study. Am J Respir Crit Care Med 2014;190:1168-76. [DOI: 10.1164/rccm.201405-0967oc] [Cited by in Crossref: 156] [Cited by in F6Publishing: 160] [Article Influence: 17.3] [Reference Citation Analysis]
150 Solsona Peiró J, de Souza Galvão ML, Altet Gómez MN. Inactive Fibrotic Lesions Versus Pulmonary Tuberculosis With Negative Bacteriology. Archivos de Bronconeumología (English Edition) 2014;50:484-9. [DOI: 10.1016/j.arbr.2014.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
151 De Keyser E, De Keyser F, De Baets F. Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection. Acta Clin Belg 2014;69:358-66. [PMID: 25018132 DOI: 10.1179/2295333714Y.0000000043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
152 Schmidt T, Schub D, Wolf M, Dirks J, Ritter M, Leyking S, Singh M, Zawada AM, Blaes-Eise AB, Samuel U, Sester U, Sester M. Comparative analysis of assays for detection of cell-mediated immunity toward cytomegalovirus and M. tuberculosis in samples from deceased organ donors. Am J Transplant 2014;14:2159-67. [PMID: 25040687 DOI: 10.1111/ajt.12787] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
153 Ulloa J, Parekh J, Hope C, Roll G. Case Report of Intestinal Tuberculosis 6 Years After Simultaneous Pancreas and Kidney Transplant. Transplantation Proceedings 2014;46:2450-2. [DOI: 10.1016/j.transproceed.2014.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
154 Al-Anazi KA, Al-Jasser AM, Alsaleh K. Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol 2014;4:231. [PMID: 25207262 DOI: 10.3389/fonc.2014.00231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
155 Subramanian AK. Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Current Opinion in Infectious Diseases 2014;27:316-21. [DOI: 10.1097/qco.0000000000000082] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
156 Lee Y, Lee S, Choi S, Kim YS, Woo JH, Kim D, Lee J, Lee J, Lee K, Kim S. A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients. Journal of Infection 2014;69:165-73. [DOI: 10.1016/j.jinf.2014.02.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
157 Santoro-Lopes G. Screening for latent tuberculosis infection in low-incidence areas. Am J Transplant 2014;14:1709. [PMID: 24888237 DOI: 10.1111/ajt.12792] [Reference Citation Analysis]
158 Vasakova M. Challenges of antituberculosis treatment in patients with difficult clinical conditions: Antituberculosis treatment in difficult conditions. The Clinical Respiratory Journal 2015;9:143-52. [DOI: 10.1111/crj.12119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
159 Solsona Peiró J, de Souza Galvão ML, Altet Gómez MN. Inactive fibrotic lesions versus pulmonary tuberculosis with negative bacteriology. Arch Bronconeumol 2014;50:484-9. [PMID: 24713269 DOI: 10.1016/j.arbres.2013.07.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
160 de Castilla DL, Rakita RM, Spitters CE, Narita M, Jain R, Limaye AP. Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates. Transplantation. 2014;97:206-211. [PMID: 24142036 DOI: 10.1097/tp.0b013e3182a94a2f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
161 Yousef AI, Ismael MF, Elshora AE, Abdou HE. Pulmonary tuberculosis in patients with chronic renal failure at Zagazig University Hospitals. Egyptian Journal of Chest Diseases and Tuberculosis 2014;63:187-192. [DOI: 10.1016/j.ejcdt.2013.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
162 de Lemos AS, Vieira MA, Halpern M, Quaresma RG, Borchardt AC, Santos MA, Gonçalves RT, Santoro-Lopes G. Results of implementation of preventive recommendations for tuberculosis after renal transplantation in an endemic area. Am J Transplant 2013;13:3230-5. [PMID: 24119248 DOI: 10.1111/ajt.12470] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
163 Flick H, Wurzinger G. Lungentuberkulose. Humanmed kompakt 2013. [DOI: 10.1007/s40355-013-0019-0] [Reference Citation Analysis]
164 Rozot V, Vigano S, Mazza-Stalder J, Idrizi E, Day CL, Perreau M, Lazor-Blanchet C, Petruccioli E, Hanekom W, Goletti D, Bart PA, Nicod L, Pantaleo G, Harari A. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol 2013;43:1568-77. [PMID: 23456989 DOI: 10.1002/eji.201243262] [Cited by in Crossref: 130] [Cited by in F6Publishing: 134] [Article Influence: 13.0] [Reference Citation Analysis]
165 Lowe D, Higgins R, Krishnan N. Meeting report: 2nd international conference: antibody incompatible transplantation and transplant infectious disease. Int J Immunogenet 2013;40:439-44. [PMID: 23919843 DOI: 10.1111/iji.12082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
166 Horne DJ, Narita M, Spitters CL, Parimi S, Dodson S, Limaye AP. Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis. 2013;57:1473-1482. [PMID: 23899676 DOI: 10.1093/cid/cit488] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
167 Flick H, Wurzinger G. Lungentuberkulose. Pneumologe 2013;10:275-294. [DOI: 10.1007/s10405-013-0681-8] [Reference Citation Analysis]
168 Hadaya K, Bridevaux P, Roux-lombard P, Delort A, Saudan P, Martin P, Janssens J. Contribution of Interferon-γ Release Assays (IGRAs) to the Diagnosis of Latent Tuberculosis Infection After Renal Transplantation. Transplantation 2013;95:1485-90. [DOI: 10.1097/tp.0b013e3182907073] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
169 Boillat-Blanco N, Aguado JM, Aubert JD, Sester M, Grossi P, Kamar N, Pascual M, Manuel O; ESCMID Study Group of Infection in Compromised Hosts. European survey on the management of tuberculosis in solid-organ transplant recipients and candidates. Transpl Int. 2013;26:e69-e70. [PMID: 23582103 DOI: 10.1111/tri.12102] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
170 Kotton CN. Travel and transplantation: travel-related diseases in transplant recipients. Curr Opin Organ Transplant 2012;17:594-600. [PMID: 23147910 DOI: 10.1097/MOT.0b013e328359266b] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
171 Ison MG, Grossi P; AST Infectious Diseases Community of Practice. Donor-derived infections in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:22-30. [PMID: 23464995 DOI: 10.1111/ajt.12095] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 11.1] [Reference Citation Analysis]
172 Goletti D, Petruccioli E, Romagnoli A, Piacentini M, Fimia GM. Autophagy in Mycobacterium tuberculosis infection: a passepartout to flush the intruder out? Cytokine Growth Factor Rev 2013;24:335-43. [PMID: 23395260 DOI: 10.1016/j.cytogfr.2013.01.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
173 Chee CB, Sester M, Zhang W, Lange C. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis: LTBI diagnosis and treatment. Respirology 2013;18:205-16. [DOI: 10.1111/resp.12002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
174 Nellore A, Kotton CN. Screening Strategies for Tuberculosis in Children With Kidney Disease: What Is Cost-Effective? American Journal of Kidney Diseases 2013;61:3-5. [DOI: 10.1053/j.ajkd.2012.10.003] [Reference Citation Analysis]
175 Bosch W, Poowanawittayakom N, Chaikriangkrai K, Mendez J, Hellinger W, Gonwa T, Krishna M, Pungpapong S. Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy. Transpl Infect Dis 2013;15:E33-9. [DOI: 10.1111/tid.12048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
176 Giehl C, Lange C, Duarte R, Bothamley G, Gerlach C, Cirillo DM, Wagner D, Kampmann B, Goletti D, Juers T, Sester M. TBNET - Collaborative research on tuberculosis in Europe. Eur J Microbiol Immunol (Bp) 2012;2:264-74. [PMID: 24265908 DOI: 10.1556/EuJMI.2.2012.4.4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
177 Kirsch S, Sester M. Tuberculosis in Transplantation: Diagnosis, Prevention, and Treatment. Curr Infect Dis Rep 2012;14:650-7. [DOI: 10.1007/s11908-012-0293-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]